n-(3-pyridylmethyl)adriamycin has been researched along with epirubicin in 2 studies
| Studies (n-(3-pyridylmethyl)adriamycin) | Trials (n-(3-pyridylmethyl)adriamycin) | Recent Studies (post-2010) (n-(3-pyridylmethyl)adriamycin) | Studies (epirubicin) | Trials (epirubicin) | Recent Studies (post-2010) (epirubicin) |
|---|---|---|---|---|---|
| 17 | 0 | 13 | 5,453 | 1,838 | 1,570 |
| Protein | Taxonomy | n-(3-pyridylmethyl)adriamycin (IC50) | epirubicin (IC50) |
|---|---|---|---|
| Genome polyprotein | 0.75 | ||
| Tyrosine-protein kinase Fyn | Homo sapiens (human) | 5.181 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adachi, K; Jenkins, GC; Jiang, XR; Macey, MG; Miki, T; Newland, AC; Yamabe, S | 1 |
| Adachi, K; Collins, PW; Gutteridge, CN; Jiang, XR; Kelsey, SM; Macey, MG; Miki, T; Newland, AC; Yamabe, S | 1 |
2 other study(ies) available for n-(3-pyridylmethyl)adriamycin and epirubicin
| Article | Year |
|---|---|
Evaluation of the in vitro antiproliferative properties of four novel anthracyclines YM1, 3, 4 and 6 in human leukemia cell lines.
Topics: Antineoplastic Agents; Cell Division; Doxorubicin; Drug Resistance; Drug Screening Assays, Antitumor; Epirubicin; Humans; Leukemia; Tumor Cells, Cultured | 1992 |
Structure-dependent antitumor activities of novel anthracyclines YM1, YM3, YM4 and YM6: drug transport properties and effects on biomacromolecule synthesis in drug sensitive and resistant leukemia cells.
Topics: Biological Transport; DNA; Doxorubicin; Drug Resistance; Epirubicin; Humans; Leukemia; Protein Biosynthesis; RNA; Structure-Activity Relationship; Tumor Cells, Cultured | 1993 |